Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic
Open Access
- 10 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Harm Reduction Journal
- Vol. 18 (1), 1-14
- https://doi.org/10.1186/s12954-021-00499-z
Abstract
People who inject drugs may be particularly vulnerable to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) due to underlying health problems, stigma and social vulnerabilities. Harm reduction services, including needle exchange programs (NEP), have been subjected to varying degrees of disruption in the world, especially in the beginning of the coronavirus disease 2019 (COVID-19) pandemic. Compared to responses in other countries, Sweden’s initial strategy toward limiting the spread and impact of COVID-19 was less restrictive to its citizens with no imposed general societal lockdown. In this study, we investigate changes in drug use patterns, utilization of NEP associated health services, COVID-19 health literacy and the prevalence of SARS-CoV-2 antibodies among NEP clients in Stockholm during the COVID-19 pandemic. NEP visits and services provided (needles/syringes, HIV and hepatitis C tests and treatment, naloxone distributed) and overall mortality among NEP clients between January 1 and October 31, 2020, were used for trend analyses in comparison with corresponding 2019 data. Between July 27 and October 2, 2020, NEP clients (n = 232) responded to a 27 item COVID-19 Health Literacy Questionnaire. SARS CoV-2 IgG antibody tests (n = 779) were performed between June 15 and October 31, 2020. During the COVID-19 pandemic number of clients, client visits, naloxone distribution and HCV tests remained stable compared to 2019, while distribution of needles/syringes increased (p < 0.0001); number of HIV tests and HCV treatments decreased (p < 0.05); and mortality decreased (< 0.01). Overall, the level of health literacy concerning transmission routes and protective measures was high. SARS-CoV-2 antibody prevalence was 5.4% (95% CI 4.0–7.2). The Stockholm NEP managed to maintain a high level of clients and services during the pandemic. In general, COVID-19 health literacy was adequate and the overall SARS-CoV-2 antibody prevalence was low compared to the general population, which highlights a need for prioritized and targeted COVID-19 vaccination among PWID.Keywords
Funding Information
- Karolinska Institute
This publication has 34 references indexed in Scilit:
- Health literacy in substance use disorder treatment: A latent profile analysisJournal of Substance Abuse Treatment, 2019
- ‘I didn’t want to let it go too far.’ The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife studyInternational Journal of Drug Policy, 2017
- Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange programInfectious Diseases, 2017
- Merchants, samaritans, and public health workers: Secondary syringe exchanger discursive practicesInternational Journal of Drug Policy, 2016
- Access to health and social services for IDU: The impact of a medically supervised injection facilityDrug and Alcohol Review, 2009
- Determinants of Cutaneous Injection-Related Infection Care at a Supervised Injecting FacilityAnnals of Epidemiology, 2009
- Accessing care for injection-related infections through a medically supervised injecting facility: A qualitative studyDrug and Alcohol Dependence, 2008
- Mortality in a cohort of opiate and amphetamine users in Perth, Western AustraliaAddiction, 2003
- Providing Hepatitis B Vaccination to Injection Drug Users: Referral to Health Clinics vs On-Site Vaccination at a Syringe Exchange ProgramAmerican Journal of Public Health, 2001
- Provision of influenza and pneumococcal vaccines to injection drug users at a syringe exchangeJournal of Substance Abuse Treatment, 2000